A Review on Emerging Infectious Diseases Prioritized Under the 2018 WHO Research and Development Blueprint: Lessons from the Indian Context
- PMID: 33316200
- DOI: 10.1089/vbz.2020.2661
A Review on Emerging Infectious Diseases Prioritized Under the 2018 WHO Research and Development Blueprint: Lessons from the Indian Context
Abstract
Objective: This review describes the current scenario of a priority group of emerging infectious diseases (EIDs) listed by World Health Organization (WHO), and their main determinants and drivers for the emergence/spread of the diseases. The gaps and strategies developed by India to meet the WHO guidelines on the effective control of epidemic-prone diseases and outbreaks are also presented in the review. Methods: Epidemiologic information of EIDs, namely Crimean-Congo hemorrhagic fever (CCHF), Ebola and Marburg viruses (EboV and MarV), Zika virus (ZIKAV), Rift Valley fever (RVF), Middle East respiratory syndrome, severe acute respiratory syndrome (SARS), Nipah and Hendra virus (NiV and HeV), and Lassa fever virus (LASV), was drawn from international and national electronic databases to assess the situation. A brief view on the novel coronavirus disease 2019 (COVID-19) in India is also included. Results: There are no reports for human infection of EboV, MarV, RVF, and LASV in India. CCHF, SARS, ZIKAV, and NiV have been involved in outbreaks in eight states of India, while COVID-19 is currently reported from majority of states. India has deeply strengthened its surveillance and response system of outbreaks and epidemic-prone diseases. Conclusions: Despite its enormous improvements made in the anticipation of such threats, still more efforts are needed in sensitization of populations as well as hospital management in the context to EIDs, as addressed in the review. Furthermore, there is still a need for more research and development activities to efficiently control EIDs.
Keywords: India; WHO R&D blueprint; control strategies; current scenario; epidemic-prone diseases.
Similar articles
-
Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases.BMJ Glob Health. 2021 Sep;6(9):e006623. doi: 10.1136/bmjgh-2021-006623. BMJ Glob Health. 2021. PMID: 34531189 Free PMC article. Review.
-
Global research trends of World Health Organization's top eight emerging pathogens.Global Health. 2017 Feb 8;13(1):9. doi: 10.1186/s12992-017-0233-9. Global Health. 2017. PMID: 28179007 Free PMC article. Review.
-
World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development.Emerg Infect Dis. 2018 Sep;24(9):e171427. doi: 10.3201/eid2409.171427. Emerg Infect Dis. 2018. PMID: 30124424 Free PMC article.
-
Emerging and Re-emerging Infectious Diseases in the WHO Eastern Mediterranean Region, 2001-2018.Int J Health Policy Manag. 2022 Aug 1;11(8):1286-1300. doi: 10.34172/ijhpm.2021.13. Epub 2021 Mar 6. Int J Health Policy Manag. 2022. PMID: 33904695 Free PMC article. Review.
-
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.Antiviral Res. 2018 Nov;159:63-67. doi: 10.1016/j.antiviral.2018.09.009. Epub 2018 Sep 24. Antiviral Res. 2018. PMID: 30261226 Free PMC article. Review.
Cited by
-
Acute neurologic emerging flaviviruses.Ther Adv Infect Dis. 2022 Jun 13;9:20499361221102664. doi: 10.1177/20499361221102664. eCollection 2022 Jan-Dec. Ther Adv Infect Dis. 2022. PMID: 35719177 Free PMC article. Review.
-
Zebrafish-based platform for emerging bio-contaminants and virus inactivation research.Sci Total Environ. 2023 May 10;872:162197. doi: 10.1016/j.scitotenv.2023.162197. Epub 2023 Feb 11. Sci Total Environ. 2023. PMID: 36781138 Free PMC article. Review.
-
Plasmodium cynomolgi in humans: current knowledge and future directions of an emerging zoonotic malaria parasite.Infection. 2023 Jun;51(3):623-640. doi: 10.1007/s15010-022-01952-2. Epub 2022 Nov 19. Infection. 2023. PMID: 36401673 Free PMC article. Review.
-
Structural and Biochemical Basis for Development of Diketo Acid Inhibitors Targeting the Cap-Snatching Endonuclease of the Ebinur Lake Virus (Order: Bunyavirales).J Virol. 2022 Apr 13;96(7):e0217321. doi: 10.1128/jvi.02173-21. Epub 2022 Mar 10. J Virol. 2022. PMID: 35266805 Free PMC article.
-
Serum biomarkers for nutritional status as predictors in COVID-19 patients before and after vaccination.J Funct Foods. 2023 Feb;101:105412. doi: 10.1016/j.jff.2023.105412. Epub 2023 Jan 10. J Funct Foods. 2023. PMID: 36644001 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous